Table of Contents
Chapter 1.Europe Inhaled Nitric Oxide Market Definition and Research Assumptions
1.1.Research Objective
1.2.Market Definition
1.3.Research Assumptions
1.3.1.Inclusion & Exclusion
1.3.2.Limitations
1.3.3.Supply Side Analysis
1.3.3.1.Availability
1.3.3.2.Infrastructure
1.3.3.3.Regulatory Environment
1.3.3.4.Market Competition
1.3.3.5.Economic Viability (Consumer's Perspective)
1.3.4.Demand Side Analysis
1.3.4.1.Regulatory frameworks
1.3.4.2.Technological Advancements
1.3.4.3.Environmental Considerations
1.3.4.4.Consumer Awareness & Acceptance
1.4.Estimation Methodology
1.5.Years Considered for the Study
1.6.Currency Conversion Rates
Chapter 2.Executive Summary
2.1.Europe Inhaled Nitric Oxide Market Size & Forecast (2022- 2032)
2.2.Regional Summary
2.3.Segmental Summary
2.3.1.By Application
2.4.Key Trends
2.5.Recession Impact
2.6.Analyst Recommendation & Conclusion
Chapter 3.Europe Inhaled Nitric Oxide Market Dynamics
3.1.Market Drivers
3.2.Market Challenges
3.3.Market Opportunities
Chapter 4.Europe Inhaled Nitric Oxide Market: Industry Analysis
4.1.Porter's 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.1.6.Futuristic Approach to Porter's 5 Force Model
4.1.7.Porter's 5 Force Impact Analysis
4.2.PESTEL Analysis
4.2.1.Political
4.2.2.Economic
4.2.3.Social
4.2.4.Technological
4.2.5.Environmental
4.2.6.Legal
4.3.Top investment opportunity
4.4.Top winning strategies
4.5.Disruptive Trends
4.6.Industry Expert Perspective
4.7.Analyst Recommendation & Conclusion
Chapter 5.Europe Inhaled Nitric Oxide Market Size & Forecasts by Application 2022-2032
5.1.Neonatal Respiratory Treatment
5.2.Chronic Obstructive Pulmonary Disease
5.3.Acute Respiratory Distress Syndrome
5.4.Others
Chapter 6.Europe Inhaled Nitric Oxide Market Size & Forecasts by Country 2022-2032
6.1.U.K. Inhaled Nitric Oxide Market
6.1.1.Application breakdown size & forecasts, 2022-2032
6.2.Germany Inhaled Nitric Oxide Market
6.3.France Inhaled Nitric Oxide Market
6.4.Spain Inhaled Nitric Oxide Market
6.5.Italy Inhaled Nitric Oxide Market
6.6.Rest of Europe Inhaled Nitric Oxide Market
Chapter 7.Competitive Intelligence
7.1.Key Company SWOT Analysis
7.2.Top Market Strategies
7.3.Company Profiles
7.3.1.Air Liquide Healthcare (France)
7.3.1.1.Key Information
7.3.1.2.Overview
7.3.1.3.Financial (Subject to Data Availability)
7.3.1.4.Product Summary
7.3.1.5.Market Strategies
7.3.2.SOL Group (Italy)
7.3.3.Merck KGaA (Germany)
7.3.4.Mallinckrodt Pharmaceuticals (United Kingdom)
Chapter 8.Research Process
8.1.Research Process
8.1.1.Data Mining
8.1.2.Analysis
8.1.3.Market Estimation
8.1.4.Validation
8.1.5.Publishing
8.2.Research Attributes